June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Epidemiology and burden of astigmatism: a systematic literature review
Author Affiliations & Notes
  • Jun Zhang
    Alcon Laboratories Inc, Fort Worth, Texas, United States
  • Mukesh Dhariwal
    Alcon Laboratories Inc, Fort Worth, Texas, United States
  • yifei wu
    Alcon Laboratories Inc, Fort Worth, Texas, United States
  • Mark A Bullimore
    University of Houston, College of Optometry, Texas, United States
  • Footnotes
    Commercial Relationships   Jun Zhang Alcon, Code E (Employment); Mukesh Dhariwal Alcon, Code E (Employment); yifei wu Alcon, Code E (Employment); Mark Bullimore Alcon, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3538 – A0118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jun Zhang, Mukesh Dhariwal, yifei wu, Mark A Bullimore; Epidemiology and burden of astigmatism: a systematic literature review. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3538 – A0118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To identify published literature on epidemiology, patient and economic burden of astigmatism through a systematic literature review. The unmet needs of astigmatic patients with co-existing ocular conditions (such as cataract, glaucoma, dry eye, presbyopia, or macular degeneration) and the risks associated with untreated astigmatism were also reviewed.

Methods : Using Cochrane methodology, a systematic literature review was conducted in MEDLINE, EMBASE, and Cochrane library (January 1996-May 2021). Studies published in the English language reporting on epidemiology and burden of astigmatism were included. Proceedings (2018-2021) from eye congresses were searched for evidence. A grey literature search was conducted using Google Scholar to identify relevant studies that were not captured by the database searches.

Results : The literature search yielded 6,804 citations, of which 125 met the inclusion criteria (epidemiology: 68; patient burden: 60; economic burden: 6) and were summarized in this SLR. The prevalence of astigmatism in the general population varied from 7.6% to 61.7%, with higher rates in older individuals (≥70 years). The prevalence of with-the-rule astigmatism was higher in the younger population (≤40 years), while rates of against-the-rule and oblique astigmatism increased with age. The prevalence of astigmatism was higher for low levels (<1.5 D: 32.7%-100%) than higher levels (≥1.5 D: 0%-39.1%). Astigmatic patients experienced decreased quality of vision, increased rates of glare (52.9%-77.0%), halos (28.1%-80.0%), night-time driving difficulties (66.0%), risk of falls (particularly with oblique astigmatism), and spectacle dependence (44.8%-85.0%) leading to decreased vision-related quality of life. Astigmatic patients performed vision-related tasks slower (-1 D: 8.9% slower, -2 D: 28.7% slower) and made more errors (-1 D: 38.1% more errors, -2 D: 370% more errors) compared to fully corrected astigmatic patients. In astigmatic patients undergoing cataract surgery, post-operative spectacle cost (mean: $51-$916), outpatient visit cost (mean: $35-$348), travel cost (mean: $14-$21), and informal care cost (mean: $39-$71) contributed to the overall economic burden.

Conclusions : Uncorrected astigmatism decreases patients' vision-related quality of life; increases productivity losses among working-age adults; and poses an economic burden on patients and their families.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×